NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

Biosect, you know this too…data and analysis ultimately approved by regulators frequently differs from data presented and published…sometimes substantially. That goes for safety as well as efficacy.

The two are independent.

Also regulators can be incredibly quick with feedback and approval when the drug is for high unmet medical need in a fatal condition...i.e., GBM.

I understand your point of view and your wanting to defend your investment. The company reads and responds to this board. It is important that they know we are sick of the silence. If they miss SNO and don’t provide guidance at the very least, Things will get ugly and LP is to blame.

And BTW Congress presentation is PEER REVIEW, not only by my standards but by FDA as well. You can market data presented at Congress without it being published.